Results 31 to 40 of about 22,846,314 (192)

Association of Total Ischemia Time with No-Reflow Phenomenon in Patients Presenting with STElevation Myocardial Infarction, Undergoing Primary Percutaneous Coronary Intervention

Pakistan Armed Forces Medical Journal, 2023
Objective: To find out the association of total ischemic time with no-reflow phenomenon, in terms of Thrombolysis in Myocardial Infarction (TIMI) flow grade, in patients presenting with ST-Elevation Myocardial Infarction and undergoing Primary ...
Waheed Ashraf, Sadaf Shabbir Kiani, Muhammad Nadir Khan, Asif Nadeem, Bakht Umar, Ayesha Sana, Javeria Kamran, Muhammad Yaseen   +7 more
doaj   +1 more source

Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention

Research in Cardiovascular Medicine, 2015
Background: The no-reflow phenomenon is an uncommon and critical occurrence which myocardial reperfusion does not restore to its optimal level. Several predisposing factors of the no-reflow phenomenon have been identified.
Seifollah Abdi, Omid Rafizadeh, Mohammadmehdi Peighambari, Hoseinali Basiri, Hooman Bakhshandeh   +4 more
doaj   +1 more source

In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention

Journal of Diabetes Research, 2021
Although percutaneous coronary intervention (PCI) significantly improves the prognosis for myocardial infarction, the no-reflow phenomenon is still the major adverse complication of PCI leading to increased mortality, especially for the patients with ST ...
Fang Liu, Rui Huang, Ya Li, Surui Zhao, Yue Gong, Zesheng Xu   +5 more
doaj   +1 more source

The no‐reflow phenomenon in coronary arteries [PDF]

Journal of Thrombosis and Haemostasis, 2004
No reflow occurs when there is inadequate myocardial perfusion of a given segment of the coronary circulation without evidence of epicardial vessel obstruction. It is a rare but clinically significant condition associated with myocardial infarction and coronary interventions. Diagnosis is usually based on clinical signs of myocardial ischemia (symptoms
R V, Kelly, M G, Cohen, M S, Runge, G A, Stouffer   +3 more
openaire   +2 more sources

reflow-project/weloop-bonfire: Reflow pilots release candidate (Bonfire comp)

, 2022
WeLoop is the first client web application developed for ReflowOS. It is a modular front-end framework intended to be used as a base for Reflow pilots to build their own ReflowOS front end interfaces customised for their unique business use cases ...
Alex Castaño, Noel De Martin, Viktor Smári, Sam Gluck, Victor Barberan, Eduard Cercós, VolodymyrPavlichenko, kariyngva, Oksana Salohubova, Guillem Camprodon, George Moschovitis, Mayel de Borniol, Alessandro Giansanti, Nicolas Wormser, Antoniskalou   +14 more
core   +1 more source

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment

Бюллетень сибирской медицины, 2009
This article presents the research findings on the impact of carvedilol on the course of the necrosis myocardium focus and malone dialdegid concentration with patients, afflicted with acute myocardial infarction.
T. Yu. Mamonova, V. A. Markov, V. V. Udut   +2 more
doaj   +1 more source

«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction [PDF]

, 2018
The aim – to determine the incidence of the «no-reflow» phenomenon (NRP) after percutaneous coronary intervention (PCI) in patients with ST elevation myocardial infarction and to investigate clinical, anamnestic and angiographic risk factors associated ...
M.M. Doloh, V.І. Tseluyko, O.A. Leonenko   +2 more
core   +2 more sources

The Relationship Between The Level Of Serum Uric Acid And No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention İn Patients With St Segment Elevated Myocardial Infarction [PDF]

Düzce Tıp Fakültesi Dergisi, 2010
No-reflow phenomenon is the absence of myocardial perfusion despite adequate dilatation ofthe infarct related coronary artery during percutaneous coronary intervention.
İsmail ERDEN, Emine Çakcak ERDEN, Serhat Bahadır SÖZEN, Osman Kayapınar, Sabri Onur ÇAĞLAR, Cengiz BAŞAR
doaj  

LncRNA MALAT1 functions as a biomarker of no-reflow phenomenon in ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention

Scientific Reports, 2022
MALAT1 was reported to sponge miR-30e, miR-126 and miR-155 in the pathogenesis of many diseases. Plasma miR-30e can indicate the risk of no-reflow during primary percutaneous coronary intervention (pPCI), while miR-126 can be used as a predictor of ...
Xiheng Yang, Rixin Dai, Zhong Qin, Ruping Cai, Yuli Xu, Qiang Su   +5 more
doaj   +1 more source

Predicting the no-reflow phenomenon following successful percutaneous coronary intervention

, 2010
In the setting of acute myocardial infarction, early and adequate reopening of an infarct-related artery is not necessarily followed by a complete restoration of myocardial perfusion. This condition is usually defined as 'no-reflow'.
Liuzzo G, Paraggio L, Galiuto L, de Caterina AR, Crea F   +4 more
core   +3 more sources